ISoP Sky Background

International Society of Pharmacovigilance

At the forefront of Pharmacovigilance around the world


What is ISoP?

The International Society of Pharmacovigilance (ISoP) is an international non-profit scientific organisation, which aims to foster Pharmacovigilance both scientifically and educationally, and enhance all aspects of the safe and proper use of medicines, in all countries. more…

ISoP Board Elections 2016

Elections open from 5th–19th September for ISoP Members only. The Election has now closed.

More Information

ISoP 2016

ISOP Prague 2015

Annual Meeting

Agra, India, 16-19 October 2016 “Pharmacovigilance for safer tomorrow”
Register now!
ISoP 2016 Agra

ISoP Training

3rd ISoP UMC Training

Lima, 7-9 September 2016
From case reports to benefit-harm assessment and risk communication.
Registrations closedISoP-UMC 2016 Lima


Education Training Programme

Education Training Programme
A primary objective of ISoP is to  promote the safest use of drugs through contributing to appropriate education. Educational Training Link

What’s New

New ISoP Statutes

Click here


René Jean Royer

WHO-ISoP PV Curriculum

PV Curriculum Databank Pilot – click here to test

Observational research in Sub-Sahara Africa

invitation to participate in a survey

EMA consultation

Draft guidelines on GPV 3 – Module V – Risk management systems and draft guidance on format of the RMP in EU cioms

Guidelines – Public Consultation

Revision of CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects – For consultation

Hervé Le Louet President ISoP

President of ISoP

As the President of ISoP, I would like to pay a tribute to all the past presidents of ESOP/ISoP for the fantastic work they did during the last 20 years and to thank all the members of the past Executive Committees for their active participation during these dedicated years…


Drug Safety

ISoP Official Journal


Drug Safety is the premier international journal covering the disciplines of pharmacovigilance, pharmacoepidemiology, benefit-risk assessment and risk management.